Matthias Napp

Title: Matthias Napp: Innovator in NEP Inhibitor Development

Introduction

Matthias Napp is a distinguished inventor based in Lörrach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of NEP inhibitors. With a total of eight patents to his name, Napp's work has advanced the understanding and production of important therapeutic compounds.

Latest Patents

Napp's latest patents focus on intermediates for producing NEP inhibitors or prodrugs thereof. The inventions detail a new process for synthesizing NEP inhibitors that include a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone. Specifically, these processes relate to the synthesis of intermediates that prepare NEP inhibitors, which are represented by specific chemical formulas. The compounds involve variations where R1 and R2 can be hydrogen or a nitrogen protecting group, while R3 is typically a carboxyl group or an ester group.

Career Highlights

Throughout his career, Matthias Napp has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharmaceuticals Corporation. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Napp has collaborated with notable professionals in his field, including David Hook and Bernard Riss. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Matthias Napp's contributions to the field of NEP inhibitors exemplify his innovative spirit and dedication to pharmaceutical research. His patents and collaborations highlight his role as a key figure in advancing therapeutic solutions.